Dundas Partners LLP Abbott Laboratories Transaction History
Dundas Partners LLP
- $1.29 Billion
- Q2 2024
A detailed history of Dundas Partners LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Dundas Partners LLP holds 330,227 shares of ABT stock, worth $38.6 Million. This represents 2.66% of its overall portfolio holdings.
Number of Shares
330,227
Previous 323,330
2.13%
Holding current value
$38.6 Million
Previous $36.8 Million
6.63%
% of portfolio
2.66%
Previous 2.89%
Shares
10 transactions
Others Institutions Holding ABT
# of Institutions
3,177Shares Held
1.33BCall Options Held
8.62MPut Options Held
7.18M-
Vanguard Group Inc Valley Forge, PA166MShares$19.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.69 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.39 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.69 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $205B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...